Basecamp Raises 140 Million for AI Designed Cell Therapies

Company Basecamp Research Event Type Series C Financing Modality AI-Designed In Vivo Cell Therapy Asset EDEN Platform / Large Serine Recombinases Target Undisclosed Disease Area Undisclosed (Platform Financing) Summary Basecamp Research announced a $140 million oversubscribed Series C led by S32, with participation from NVIDIA…